The competing lawsuits over the companies' two vaccines, which helped save millions of lives and made the companies billions of dollars, are just one strand of ongoing litigation around the world ...
In launching Ixchiq, Valneva is targeting four types of customers, CEO Thomas Lingelbach ... such as Pfizer, Moderna and AstraZeneca gained approvals for their COVID vaccines by the end of 2020 ...
Myriad publications have falsely warned readers about "turbo cancer," a purportedly aggressive form of cancer caused by mRNA vaccines like the Pfizer and Moderna ... increase in cancer cases due ...
News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday. Moderna CEO ...
Just 41% of the nursing home residents in the United States have received the updated COVID-19 vaccine even though they are more likely to be infected by the illness than other people ...
Researchers from St George's, University of London have identified key barriers to vaccine uptake for whooping cough, flu and COVID-19 in ... vaccine hesitancy and increase protection of mothers ...
A review of death certificates in Oregon failed to turn up evidence of a greater risk of sudden cardiac death among individuals ages 16 to 30 who had recently received a COVID-19 vaccine, researchers ...
But Trump has largely refrained from touting the vaccines since 2021, when he was booed at an Alabama rally and an appearance in Dallas after saying he had received a COVID jab. “I really don ...
Optimizing Boosters: How COVID ... century-old vaccine reduced tumors and extended survival for mice with liver ... Feb. 20, 2024 — A study has shown that shortly after an increase in ...
In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited ...
Moderna's COVID-19 Vaccine Safe and Effective for Young Children, Study Finds Nov. 4, 2022 — Moderna's COVID-19 vaccine is safe and effective in children 6 months to 5 years of age, a clinical ...